文献速递肿瘤 PET/CT放射性药物与辐射防护

18F-PTTP PET显像剂用于鉴别肺部肿瘤与炎症

P2X7 PET Radioligand 18F-PTTP for Differentiation of Lung Tumor from Inflammation.
PubMed 文献 · J Nucl Med · 2019-01-17

研究评估了靶向P2X7受体的18F标记示踪剂18F-PTTP在区分炎症与肿瘤中的价值。在A549荷瘤小鼠和炎症模型小鼠中,18F-PTTP在炎症部位5分钟达峰值并持续至30分钟可显像,而肿瘤移植瘤在注射后1小时内未见明显摄取。研究表明18F-PTTP是有潜力的P2X7R靶向放射性配体,可区分炎症与某些实体瘤。

要点

  • 18F-PTTP靶向P2X7受体,炎症模型小鼠5分钟摄取达峰,30分钟内可显像。
  • A549肿瘤移植瘤在注射后1小时内未见明显放射性摄取。
  • 阻断实验和组织学分析验证了18F-PTTP靶向P2X7R的特异性。

核心结论

  • 18F-PTTP是靶向P2X7R的新型放射性配体,有潜力用于筛选新药、量化外周炎症及区分炎症与某些实体瘤。

研究设计与样本

  • 研究通过一步18F-三氟甲基化反应合成18F-PTTP,体外评估其与P2X7R的结合亲和力和稳定性,体内进行血液药代动力学测试和生物分布研究。
  • 对A549荷瘤小鼠和炎症模型小鼠进行60分钟动态18F-PTTP小动物PET/CT显像以评估靶向区分能力。

主要发现

  • 18F-PTTP衰变校正放射化学产率为2.5%-7.0%,比活度为296-370 MBq/μmol,放射化学纯度超过95%。
  • 18F-PTTP在0.9% NaCl和0.1%牛血清白蛋白中稳定性优异,对RAW264.7细胞有良好亲和力,在小鼠体内血液清除迅速。
  • 炎症模型小鼠中18F-PTTP摄取在注射后5分钟达峰,持续至30分钟保持可显像水平;肿瘤移植瘤在注射后1小时内未见明显放射性摄取。

临床怎么用

  • 18F-PTTP PET显像有望用于鉴别炎症与某些实体瘤,并可用于外周炎症的量化评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Site-specific imaging agents play a key role in tumor targeting, but only a few agents are currently available for inflammation targeting. Since the P2X7 receptor (P2X7R) is a promising molecular target for inflammation, we evaluated the potential value of the 18F-labeled tracer 18F-PTTP (5-{[2-Chloro-3-(trifluoromethyl)phenyl]carbonyl}-1-pyrimidin-2-yl-4,5,6,7-tetrahydro-1H-[1,2,3]triazolo[4,5-c]pyridin) for targeting P2X7Rs and thus differentiating inflammation from tumors. Methods: The radioligand 18F-PTTP was achieved by a 1-step 18F-trifluoromethylation reaction. The binding affinity of the ligand for P2X7R and its stability were evaluated in vitro. Blood pharmacokinetics tests and biodistribution studies were performed in vivo. Dynamic 18F-PTTP small-animal PET/CT imaging was performed for 60 min on A549 tumor-bearing mice and inflammation-model mice for targeting differentiation. Results:18F-PTTP was afforded with decay-corrected radiochemical yields of 2.5%-7.0%, specific activity of 296-370 MBq/μmol, and radiochemical purity over 95%. 18F-PTTP showed excellent stability in 0.9% NaCl and 0.1% bovine serum albumin, good affinity to RAW264.7 cells, and rapid blood clearance in mice. In inflammation-model mice, uptake of 18F-PTTP peaked at 5 min after injection and kept at an imageable level till 30 min, whereas no significant radioactivity uptake was found in tumor grafts till 1 h after injection. The specificity of 18F-PTTP was verified by blocking studies and histologic analysis. Conclusion: The current study provides compelling data that 18F-PTTP is a novel radioligand targeting P2X7R and has potential to screen new drugs, quantify peripheral inflammation, and distinguish inflammation from certain solid tumors.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Fu Z, Lin Q, Hu B, et al. P2X7 PET Radioligand 18F-PTTP for Differentiation of Lung Tumor from Inflammation. J Nucl Med. 2019. PMID: 30655332. doi:10.2967/jnumed.118.222547

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。